Actively Recruiting
Phase II Study Evaluating Trastuzumab Deruxtecan Drug Levels and Effectiveness in Breast Cancer Patients with Brain Metastases
Led by Fudan University · Updated on 2026-06-17
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying breast cancer patients who develop brain metastases, a condition affecting about 5-15% of this population. Current local treatments like surgery and radiotherapy can have serious complications, while systemic therapies show limited effectiveness. This study focuses on patients with HER2-low expressing breast cancer and aims to explore safer and more effective systemic treatment options, specifically investigating trastuzumab deruxtecan in this group. This is a Phase II observational clinical study evaluating the relationship between the concentration of trastuzumab deruxtecan in cerebrospinal fluid and its effectiveness against brain metastases. The study includes two cohorts one with patients without central nervous system metastases and another with patients who have brain parenchymal metastases confirmed by MRI. Researchers will collect cerebrospinal fluid samples before treatment, shortly after infusion starts, and at disease progression to assess drug levels and response. Participants will undergo intravenous trastuzumab deruxtecan treatment and regular assessments for up to 24 months. These include brain imaging, neurologic evaluations, and quality of life questionnaires. Researchers will monitor intracranial response, progression-free survival, overall survival, adverse events, and other clinical outcomes. The study also aims to detect leptomeningeal metastases early via lumbar puncture to improve prognosis and will track participants health status closely during follow-up.
CONDITIONS
Brief Title
A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here